HEADER TRANSCRIPTION 09-OCT-07 2RHU TITLE CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 BOUND TO TITLE 2 DIMETHYL-LYSINE AND IN CHIMERA WITH HISTONE H3.3(28-34) COMPND MOL_ID: 1; COMPND 2 MOLECULE: LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: REPEATES MBT-1, MBT-2, MBT-3; RESIDUES 206-519; COMPND 5 SYNONYM: L3, MBT-LIKE, L3, MBT PROTEIN HOMOLOG, H-L3, MBT PROTEIN, H- COMPND 6 L3, MBT, L3MBTL1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: L3MBTL, KIAA0681, L3MBT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX6P KEYWDS BETA BARREL, PROTEIN-PEPTIDE COMPLEX, DIMETHYL-LYSINE, ALTERNATIVE KEYWDS 2 SPLICING, CHROMATIN REGULATOR, DNA-BINDING, METAL-BINDING, NUCLEUS, KEYWDS 3 REPRESSOR, TRANSCRIPTION, TRANSCRIPTION REGULATION, ZINC, ZINC- KEYWDS 4 FINGER EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,D.J.PATEL REVDAT 4 15-NOV-23 2RHU 1 REMARK REVDAT 3 30-AUG-23 2RHU 1 SEQADV LINK REVDAT 2 24-FEB-09 2RHU 1 VERSN REVDAT 1 11-DEC-07 2RHU 0 JRNL AUTH H.LI,W.FISCHLE,W.WANG,E.M.DUNCAN,L.LIANG,S.MURAKAMI-ISHIBE, JRNL AUTH 2 C.D.ALLIS,D.J.PATEL JRNL TITL STRUCTURAL BASIS FOR LOWER LYSINE METHYLATION STATE-SPECIFIC JRNL TITL 2 READOUT BY MBT REPEATS OF L3MBTL1 AND AN ENGINEERED PHD JRNL TITL 3 FINGER. JRNL REF MOL.CELL V. 28 677 2007 JRNL REFN ISSN 1097-2765 JRNL PMID 18042461 JRNL DOI 10.1016/J.MOLCEL.2007.10.023 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 37183 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2232 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2490 REMARK 3 BIN FREE R VALUE : 0.2840 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 212 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2623 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 522 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.490 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RHU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-OCT-07. REMARK 100 THE DEPOSITION ID IS D_1000044876. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38237 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.06800 REMARK 200 R SYM (I) : 0.06800 REMARK 200 FOR THE DATA SET : 26.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.41400 REMARK 200 R SYM FOR SHELL (I) : 0.41400 REMARK 200 FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1OZ2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WAS GENERATED BY PRE REMARK 280 -INCUBATING THE L3MBTL1-H3.3(28-34) (18MG/ML IN 50MM KCL, 25MM REMARK 280 TRIS-HCL PH 8.0, 1MM DTT) WITH A FIVE-FOLD MOLAR EXCESS OF REMARK 280 DIMETHYL-LYSINE AMINO ACID. DROPS WERE PREPARED BY MIXING EQUAL REMARK 280 VOLUMES OF THE COMPLEX WITH RESERVOIR SOLUTION (5% PEG10K, 0.1 M REMARK 280 TRIS-MALEATE PH 6.5, 0.1 M AMMONIUM SULFATE), VAPOR DIFFUSION, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 42.58300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.01150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.58300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.01150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 983 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 201 REMARK 465 PRO A 202 REMARK 465 LEU A 203 REMARK 465 GLY A 204 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 359 C - N - CA ANGL. DEV. = 10.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 251 64.20 -160.20 REMARK 500 GLN A 336 10.52 -140.14 REMARK 500 ASP A 372 -119.03 53.25 REMARK 500 ASP A 384 3.12 -68.44 REMARK 500 ASN A 421 32.38 -96.94 REMARK 500 LYS A 442 77.43 -114.46 REMARK 500 ASN A 452 -13.11 85.38 REMARK 500 LEU A 455 -168.98 -160.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2RHI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT DOMAIN FROM HUMAN L3MBTL1 IN COMPLEX REMARK 900 WITH H1.5K27ME2 AT 1.66 ANGSTROM REMARK 900 RELATED ID: 2RHX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 BOUND TO REMARK 900 DIMETHYL-LYSINE REMARK 900 RELATED ID: 2RHY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 BOUND TO REMARK 900 MONOMETHYL-LYSINE REMARK 900 RELATED ID: 2RHZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 WITH REMARK 900 D355N POINT MUTATION REMARK 900 RELATED ID: 2RI2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 WITH REMARK 900 D355A POINT MUTATION REMARK 900 RELATED ID: 2RI3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 WITH REMARK 900 N358Q POINT MUTATION REMARK 900 RELATED ID: 2RI5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE 3-MBT REPEATS FROM HUMAN L3MBTL1 WITH REMARK 900 N358A POINT MUTATION REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE C-TERMINAL SEQUENCE SAPSTGG REPRESENTS THE REMARK 999 FUSED PROTEIN SEQUENCE FROM HISTONE H3.3(28-34) DBREF 2RHU A 206 519 UNP Q9Y468 LMBTL_HUMAN 206 519 SEQADV 2RHU GLY A 201 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHU PRO A 202 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHU LEU A 203 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHU GLY A 204 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHU SER A 205 UNP Q9Y468 EXPRESSION TAG SEQADV 2RHU GLY A 520 UNP Q9Y468 LINKER SEQADV 2RHU GLY A 521 UNP Q9Y468 LINKER SEQADV 2RHU GLY A 522 UNP Q9Y468 LINKER SEQADV 2RHU SER A 523 UNP Q9Y468 SEE REMARK 999 SEQADV 2RHU ALA A 524 UNP Q9Y468 SEE REMARK 999 SEQADV 2RHU PRO A 525 UNP Q9Y468 SEE REMARK 999 SEQADV 2RHU SER A 526 UNP Q9Y468 SEE REMARK 999 SEQADV 2RHU THR A 527 UNP Q9Y468 SEE REMARK 999 SEQADV 2RHU GLY A 528 UNP Q9Y468 SEE REMARK 999 SEQADV 2RHU GLY A 529 UNP Q9Y468 SEE REMARK 999 SEQRES 1 A 329 GLY PRO LEU GLY SER TRP SER TRP GLU SER TYR LEU GLU SEQRES 2 A 329 GLU GLN LYS ALA ILE THR ALA PRO VAL SER LEU PHE GLN SEQRES 3 A 329 ASP SER GLN ALA VAL THR HIS ASN LYS ASN GLY PHE LYS SEQRES 4 A 329 LEU GLY MET LYS LEU GLU GLY ILE ASP PRO GLN HIS PRO SEQRES 5 A 329 SER MET TYR PHE ILE LEU THR VAL ALA GLU VAL CYS GLY SEQRES 6 A 329 TYR ARG LEU ARG LEU HIS PHE ASP GLY TYR SER GLU CML SEQRES 7 A 329 HIS ASP PHE TRP VAL ASN ALA ASN SER PRO ASP ILE HIS SEQRES 8 A 329 PRO ALA GLY TRP PHE GLU LYS THR GLY HIS LYS LEU GLN SEQRES 9 A 329 PRO PRO LYS GLY TYR LYS GLU GLU GLU PHE SER TRP SER SEQRES 10 A 329 GLN TYR LEU ARG SER THR ARG ALA GLN ALA ALA PRO LYS SEQRES 11 A 329 HIS LEU PHE VAL SER GLN SER HIS SER PRO PRO PRO LEU SEQRES 12 A 329 GLY PHE GLN VAL GLY MET LYS LEU GLU ALA VAL ASP ARG SEQRES 13 A 329 MET ASN PRO SER LEU VAL CYS VAL ALA SER VAL THR ASP SEQRES 14 A 329 VAL VAL ASP SER ARG PHE LEU VAL HIS PHE ASP ASN TRP SEQRES 15 A 329 ASP ASP THR TYR ASP TYR TRP CYS ASP PRO SER SER PRO SEQRES 16 A 329 TYR ILE HIS PRO VAL GLY TRP CYS GLN LYS GLN GLY LYS SEQRES 17 A 329 PRO LEU THR PRO PRO GLN ASP TYR PRO ASP PRO ASP ASN SEQRES 18 A 329 PHE CML TRP GLU LYS TYR LEU GLU GLU THR GLY ALA SER SEQRES 19 A 329 ALA VAL PRO THR TRP ALA PHE LYS VAL ARG PRO PRO HIS SEQRES 20 A 329 SER PHE LEU VAL ASN MET LYS LEU GLU ALA VAL ASP ARG SEQRES 21 A 329 ARG ASN PRO ALA LEU ILE ARG VAL ALA SER VAL GLU ASP SEQRES 22 A 329 VAL GLU ASP HIS ARG ILE LYS ILE HIS PHE ASP GLY TRP SEQRES 23 A 329 SER HIS GLY TYR ASP PHE TRP ILE ASP ALA ASP HIS PRO SEQRES 24 A 329 ASP ILE HIS PRO ALA GLY TRP CYS SER LYS THR GLY HIS SEQRES 25 A 329 PRO LEU GLN PRO PRO LEU GLY GLY GLY GLY SER ALA PRO SEQRES 26 A 329 SER THR GLY GLY MODRES 2RHU CML A 278 CYS MODRES 2RHU CML A 423 CYS HET CML A 278 14 HET CML A 423 14 HET SO4 A 1 5 HET MLY A 530 12 HET PG4 A 531 13 HET PEG A 2 7 HETNAM CML (2S)-2-{[(2R)-2-AMINO-2- HETNAM 2 CML CARBOXYETHYL]SULFANYL}BUTANEDIOIC ACID HETNAM SO4 SULFATE ION HETNAM MLY N-DIMETHYL-LYSINE HETNAM PG4 TETRAETHYLENE GLYCOL HETNAM PEG DI(HYDROXYETHYL)ETHER FORMUL 1 CML 2(C7 H11 N O6 S) FORMUL 2 SO4 O4 S 2- FORMUL 3 MLY C8 H18 N2 O2 FORMUL 4 PG4 C8 H18 O5 FORMUL 5 PEG C4 H10 O3 FORMUL 6 HOH *522(H2 O) HELIX 1 1 SER A 207 LYS A 216 1 10 HELIX 2 2 PRO A 221 PHE A 225 5 5 HELIX 3 3 GLN A 226 VAL A 231 1 6 HELIX 4 4 SER A 276 ASP A 280 5 5 HELIX 5 5 GLY A 294 GLY A 300 1 7 HELIX 6 6 LYS A 310 PHE A 314 5 5 HELIX 7 7 SER A 315 ARG A 324 1 10 HELIX 8 8 PRO A 329 PHE A 333 5 5 HELIX 9 9 ASP A 383 ASP A 387 5 5 HELIX 10 10 GLY A 401 GLY A 407 1 7 HELIX 11 11 ASP A 418 PHE A 422 5 5 HELIX 12 12 CML A 423 GLY A 432 1 10 HELIX 13 13 PRO A 437 PHE A 441 5 5 HELIX 14 14 SER A 487 ASP A 491 5 5 HELIX 15 15 GLY A 505 GLY A 511 1 7 SHEET 1 A 5 PHE A 281 ASN A 284 0 SHEET 2 A 5 ARG A 267 PHE A 272 -1 N LEU A 270 O PHE A 281 SHEET 3 A 5 HIS A 251 CYS A 264 -1 N ALA A 261 O ARG A 269 SHEET 4 A 5 LYS A 243 ASP A 248 -1 N LEU A 244 O LEU A 258 SHEET 5 A 5 ILE A 290 HIS A 291 -1 O HIS A 291 N GLU A 245 SHEET 1 B 5 TYR A 388 CYS A 390 0 SHEET 2 B 5 ARG A 374 PHE A 379 -1 N PHE A 375 O CYS A 390 SHEET 3 B 5 ASN A 358 VAL A 371 -1 N SER A 366 O HIS A 378 SHEET 4 B 5 LYS A 350 ASP A 355 -1 N ALA A 353 O CYS A 363 SHEET 5 B 5 ILE A 397 HIS A 398 -1 O HIS A 398 N GLU A 352 SHEET 1 C 4 TYR A 388 CYS A 390 0 SHEET 2 C 4 ARG A 374 PHE A 379 -1 N PHE A 375 O CYS A 390 SHEET 3 C 4 ASN A 358 VAL A 371 -1 N SER A 366 O HIS A 378 SHEET 4 C 4 LEU A 410 THR A 411 1 O THR A 411 N VAL A 362 SHEET 1 D 5 PHE A 492 ASP A 495 0 SHEET 2 D 5 ARG A 478 PHE A 483 -1 N ILE A 481 O PHE A 492 SHEET 3 D 5 ILE A 466 VAL A 474 -1 N GLU A 472 O LYS A 480 SHEET 4 D 5 LYS A 454 VAL A 458 -1 N LEU A 455 O ALA A 469 SHEET 5 D 5 ILE A 501 HIS A 502 -1 O HIS A 502 N GLU A 456 LINK C GLU A 277 N CML A 278 1555 1555 1.33 LINK C CML A 278 N HIS A 279 1555 1555 1.33 LINK C PHE A 422 N CML A 423 1555 1555 1.33 LINK C CML A 423 N TRP A 424 1555 1555 1.33 CRYST1 85.166 94.023 59.187 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011742 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010636 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016896 0.00000